05/12/2022 Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multi-center Registry-based Study Retinoblastoma is the most common childhood eye cancer. Though potentially curable at early stages, a significant proportion of cases arise in Asia and Africa...
04/29/2022 Dr. Paul T. Finger has been named one of New York Metro's Top Doctors of 2022! The Eye Care Foundation is proud to congratulate our Founder and Chairman, Dr. Paul T. Finger, on being named one of the top doctors of 2022! Dr. Finger has been a prominent figure in the ophthalmology world. Not only has he...
04/21/2022 High-Risk Pathology Based on Presenting Features in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing AJCC Study Retinoblastoma is the most common eye cancer in childhood. Timely diagnosis and protocol-based management can achieve excellent survival. However, the...
03/25/2022 The Spring 2022 Visionary is here The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research, and global efforts focused on improving eye cancer treatment, diagnosis, and cure. In this edition, you will find articles about: The 2022 fellows' successful training...
2/25/2022 The Eye Cancer Foundation is awarded the 2022 Platinum Seal Award For the third year in a row, The Eye Cancer Foundation has been awarded the Platinum Seal of Transparency by GuideStar, the leading source of information on non-profits within the United States. The ECF is pleased that donors, current and...
2/04/2022 World Cancer Day: World Retinoblastoma Awareness In honor of World Cancer Day, Dr. Finger and Dr. Yacoub Yousef have created and presented an informational video about Retinoblastoma treatment around the world, and what needs to be improved to maximize on care for eye cancer patients...
2/03/2022 The ECF would like to congratulate Dr. Vincent Sun on completion of his fellowship! From July 1st 2021 to February 1st 2022, Dr. Vincent Sun trained under Dr. Paul Finger in New York to complete a fellowship in ocular tumor, orbital disease and ophthalmic radiation therapy! While in New York City, Dr. Sun exhibited...
1/28/2022 Retinoblastoma Outcomes: A Global Perspective Retinoblastoma is the most common pediatric eye cancer, and is typically curable through early diagnosis and protocol-based management. In fact, advanced medical care delivery in high-income regions has provided excellent rates of survival, and globe...
1/04/2022 Patients presenting with Stage IV uveal melanoma Patients presenting with choroidal melanoma must be checked for metastatic “Stage IV” melanoma before their eye surgery. What makes this difficult is that in the modern era, almost all patients have no symptoms and most centers only check the liver for metastasis...
12/14/2021 Dr. Paul T. Finger has been inducted into the Retina Hall of Fame! The Eye Care Foundation is proud to congratulate our Founder and Chairman, Dr. Paul T. Finger on being inducted into the Retina Hall of Fame! In 1998, Paul T. Finger, MD established The Eye Cancer Foundation as an educational and supportive...
11/24/2021 Dr. Yacoub Yousef receives the King Hussein Award for Excellence in Cancer Research! Dr. Yousef, a Senior Fellow and of The Eye Cancer Foundation was trained by Drs. Paul T Finger and Brenda Gallie. Today, we are pleased to announce that he was awarded the King Hussein Award or Excellence in Cancer...
11/12/2021 Springer Publishers has Reported The Eye Cancer Foundation Sponsored Open-Access Eye Cancer Surgery Textbook to be More Popular than Expected! At the 2014, ECF-sponsored First Eye Cancer Working Day (Curie Institute, Paris France), Drs. Finger and Santosh Honavar suggested that an open-access...
10/18/2021 The ECF has sponsored another fellow who has completed their Ophthalmic Oncology Training in Cambodia! Cambodian fellow, Lom Orng Kiry, MD was one of the few successful ECF candidates to complete a fellowship during the devastating time of Covid-19. She travelled to India and was trained by our Scientific Board..
09/27/2021 An ECF fellow, Dr. Gaurav Garg, has been selected for the Best Abstract (Free Paper) Award Dr. Garg's paper on Patients Presenting with Metastases: Stage IV Uveal Melanoma, an International Study, has recently been selected for Best Free Paper Award for Asia Pacific Vitreo-retina Society (APVRS) 2021. This...
09/16/2021 OCT-A evaluation of radiation vasculopathy following slotted plaque brachytherapy A new non-invasive technology called, Optical Coherence Tomography Angiography or OCTA, can image the very small retinal blood vessels without contrast dye. Drs. Paul T. Finger, Dr. Anthony Fam & Dr. Ankit Tomar’s research to seen if...
09/09/2021 New Intravitreal Injection Methods Dr. Finger wrote this lecture to share this experience with intravitreal injections. Since he first used intraviteral anti-VEGF agents for the treatment of radiation maculopathy and optic neuropathy, there has been quite an evolution of his intravitreal methods. Most methods for...
08/03/2021 AJCC 8th edition TNMH Retinoblastoma Staging: The One Multi-Purpose Staging System Funded by The Myrna and John Daniels Family, The Paul Finger Fund and The Eye Cancer Foundation, an internet-based data-research repository was created to evaluate the American Joint Committee on...
07/06/2021 Donor Generosity Provides Ophthalmology Equipment For Our Fellowship Program Graduate Due to the generosity of our Board Member, Ms. Lynne Shevlin, The Eye Cancer Foundation was able to send a state-of-the-art indirect ophthalmoscope to one of our eye cancer fellows, in the Philip...
06/27/2021 The All India Ophthalmological Meeting: Keynote Speaker, Dr. Paul Finger In 2003, I was selected to chair the 7th All India Ophthalmological Meeting edition American Joint Committee on Cancer's -AJCC effort for ophthalmic oncology.I knew that the 6th edition was not being used, so I created the AJCC...
06/11/2021 Presenting The Spring 2021 Visionary The Spring 2021 issue of The Eye Cancer Foundation's Visionary magazine is now available! The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research and global efforts focused on improving eye cancer...
06/11/2021 The Eye Cancer Foundation Awarded 2021 Platinum Seal of Transparency by GuideStar For the second year in a row, The Eye Cancer Foundation has been awarded the Platinum Seal of Transparency by GuideStar, the leading source of information on non-profits within the United States. The ECF is pleased that...
05/19/2021 Patient Story: Eye Saved From Enucleation Through Eye Cancer Network It comes as no question eye cancer care is not readily available in all corners of the world, hence the work and mission of The Eye Cancer Foundation. This is especially true of countries in the Middle East, where more aggressive forms...
05/13/2021 ECF Supported Research Featured in New York Eye and Ear Infirmary 200 Years Celebration The New York Eye and Ear Infirmary of Mount Sinai is celebrating 200 years of providing innovative, first-class care to patients with ocular diseases. At the core of the infirmary's Ocular Oncology...
04/05/2021 Patients Presenting with Stage IV Metastatic Uveal Melanoma Examined in New ECF Supported Study Uveal melanoma is classified as Stage IV when there are metastasis. A multi-center, international collaborative registry study was recently published in the British Journal of Ophthalmology...
03/29/2021 The ECF Sponsors New Study Assessing Ophthalmic Radiation Therapy Outcomes Alongside the Myrna and John Daniels Fund at the Princess Margaret Cancer Center, The Eye Cancer Foundation is proud to co-sponsor the Study of Ophthalmic Radiation Therapy Toxicity (SORTT). Through the international...
